THE EFFECT OF DOSE ESCALATION ON TROUGH LEVELS IN PATIENTS WHO LOST RESPONSE TO INFLIXIMAB

(1) University Hospital Leuven, Dept. of Gastroenterology, Leuven, Belgium

(2) Laboratory for PharmaceuticalBiology, Leuven, Belgium

(3) Gastroenterology, UNIVERSITYHOSPITALS LEUVEN, Leuven, Belgium

(4) University Hospitals Leuven, Dept. of Gastroenterology, Leuven, Belgium



This item was part of the Anti-TNF in IBD: Mono versus combo - safety matters session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A81